NextCure has signed a licensing deal valued at up to $745 million for the rights...
UroGen Pharma has received FDA approval for its intravesical therapy, Zusduri, m...
GSK has licensed its Shigella vaccine candidate, altSonflex1-2-3, to Bharat Biot...
EHA 2025: Surovatamig shows promise, but needs to outperform established therapi...
Shares in both companies were down following news of the second death, casting f...
Ethris has entered a strategic partnership with Thermo Fisher Scientific for pro...
NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep...
NextCure has entered a strategic partnership with Simcere Zaiming, to develop SI...
After Biogen failed with a takeover bid in January, Supernus has swooped in to b...
MSD has received US Food and Drug Administration (FDA) approval for its anti-pro...
DETROIT – Recent advancements in environmental health sciences have brought grow...
In a groundbreaking study poised to redefine neonatal cardiology, researchers ha...
In the rapidly advancing field of generative artificial intelligence, the qualit...
In a groundbreaking advancement for public health, Emory University, in collabor...
In a groundbreaking advancement with far-reaching implications for sustainable c...
